Lysophosphatidic Acid (LPA) Screening Service

The Lysophosphatidic Acid (LPA) Screening Service uses the LPA ELISA II (cat# K-2800s) to quantify LPA in biological samples. LPA is a serum-derived phospholipid involved in diverse cellular processes such as cell proliferation, chemotaxis, platelet aggregation, wound healing, angiogenesis, tumor invasion, and smooth muscle contraction. Recent research indicates LPA may play a significant role in the pathophysiology of cancer and may be used as a biomarker for ovarian cancer. Several literature citations indicate plasma LPA levels are elevated in ovarian cancer patients.

  • Echelon has 25 years of ELISA expertise and 15 years experience in the LPA field.
  • Your samples are cataloged and stored according to your requirements.
  • The LPA Screening Service will run each sample in duplicate.
  • Results are provided as an average of the duplicate points in μM LPA .
  • Usually results are provided 2 weeks from receipt of samples. We can accommodate tighter schedules if needed.

Contact us for a quote on your custom assay service.

Description

Contact Us

Fill out the form below to receive a full quote for this service.

Publications

Citations listed are from the LPA ELISA II (catalog number K-2800S).

Shopping Cart
Scroll to Top